GO:0044548 S100 protein binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044548 (S100 protein binding) is a biological_process term describing the selective interaction of a protein with an S100-family calcium-binding protein [1,8].
• S100 proteins are EF-hand calcium sensors that change conformation upon calcium binding and then engage specific target proteins, including annexins, tropomyosin and ubiquitin-ligase components [4,5,6].
• S100 protein binding underlies diverse processes such as embryo implantation, tumor progression, rheumatoid arthritis and glioma proliferation [1,2,3,7].
• The interaction is frequently studied by co-immunoprecipitation, crosslinking, affinity purification and structural methods such as crystallography and NMR [5,8].
• Dysregulated S100 protein binding is implicated in cancer, inflammatory disease and developmental disorders, making it a target for functional genomics [2,3,7].
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of S100 protein binding interfaces and downstream signaling [3,8].
Description
GO:0044548, S100 protein binding, is a Gene Ontology biological_process term that captures the event in which a protein physically and selectively associates with a member of the S100 family of calcium-binding proteins [1,8]. S100 proteins are small EF-hand proteins that act as calcium sensors and modulate numerous intracellular and extracellular targets; their binding to partner proteins is therefore a central node in calcium signal transduction [1,6]. The term is used by researchers to annotate gene products whose function depends on direct contact with an S100 protein, rather than on S100 expression alone. Because S100 protein binding is a process annotation, it is often studied together with the molecular functions of the individual S100 proteins and their targets [5,6]. Understanding this term helps interpret functional genomics data, because loss of an S100 binding interface can phenocopy loss of the S100 protein itself in processes such as embryo implantation and tumor growth [1,3]. The term also provides a controlled vocabulary for comparing S100-dependent mechanisms across cell types, from trophoblast invasion to glioma proliferation [1,3]. As a result, GO:0044548 is a useful entry point for researchers designing CRISPR screens or biochemical assays that interrogate calcium-dependent protein-protein interactions [3,8].
S100 protein binding At A Glance
| GO ID | GO:0044548 |
|---|---|
| GO term | S100 protein binding |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Binding of a protein to an S100-family calcium-binding protein, often in a calcium-dependent manner [1,6] |
| Example partners | Annexins, nonmuscle tropomyosin, CUL4A-associated complexes [4,5,3] |
| Associated processes | Embryo implantation, tumor progression, inflammation, glioma proliferation [1,2,7,3] |
| Detection methods | Co-immunoprecipitation, crosslinking, affinity purification, structural biology [5,8] |
| Disease relevance | Cancer, rheumatoid arthritis, developmental and implantation disorders [2,7,1] |
What Is GO:0044548?
In our own words, GO:0044548 describes the biological process in which a protein binds to an S100-family protein. The interaction is typically calcium-dependent, because S100 proteins expose their target-binding surfaces only after calcium-induced conformational change [1,6]. The term is not restricted to a single S100 member or a single partner; it covers any physiologically relevant binding event between a non-S100 protein and an S100 protein. This process annotation is therefore broader than a molecular function term such as calcium ion binding, and it emphasizes the downstream biological context in which the S100-target complex acts [5,8].
Why Is S100 protein binding Important in Cell Biology?
S100 protein binding is important because it converts transient calcium signals into specific cellular outcomes, and because disruption of these interactions is repeatedly observed in human disease [1,6,7]. For example, S100 protein family members participate in embryo implantation, breast tumor biology and rheumatoid arthritis, where their binding to partner proteins influences cell migration, proliferation and inflammatory signaling [1,2,7]. In glioma, S100A16 binding to components of the Hippo pathway machinery promotes proliferation by triggering LATS1 ubiquitin degradation. Because the process is defined by physical interaction rather than by expression level, it provides a mechanistic readout that can be perturbed precisely with CRISPR-based models [3,8].
• S100 protein binding translates calcium signals into specific protein-protein interactions [1,6].
• It is required for normal embryo implantation and trophoblast function.
• It contributes to breast tumor progression and is studied as a cancer biomarker axis.
• It promotes glioma cell proliferation through Hippo pathway inhibition.
• It is implicated in rheumatoid arthritis and inflammatory joint disease.
• It involves structurally characterized complexes such as S100-annexin assemblies.
• It can be modulated by transition metal binding to S100 proteins.
• It is experimentally tractable by co-immunoprecipitation and crosslinking.
• It provides a functional annotation for CRISPR screens targeting calcium signaling.
• It links extracellular cues to intracellular ubiquitin-ligase and cytoskeletal machinery [3,4].
What Happens During S100 protein binding?
Calcium-dependent activation of the S100 protein
In simple terms: Calcium acts like a switch that changes the shape of the S100 protein so it can grab its partner.
S100 proteins are EF-hand calcium-binding proteins that undergo conformational change upon calcium binding, exposing hydrophobic surfaces that are required for target recognition [1,6]. This step is the prerequisite for GO:0044548, because without calcium the S100 protein typically remains in a closed, low-affinity state. Transition metals can also bind S100 proteins and modulate their behavior, adding a layer of regulation to the process.
Recognition and physical association with the target protein
In simple terms: Once activated, the S100 protein docks onto a specific partner protein.
The activated S100 protein binds a defined surface on its partner, forming a complex that can be isolated by co-immunoprecipitation or crosslinking. Well-characterized examples include the binding of an S100-related calcium-binding protein to nonmuscle tropomyosin, which links the process to cytoskeletal regulation. Structural studies of S100-annexin complexes have revealed how the interface is organized and how calcium controls it.
Formation of functional S100-target complexes
In simple terms: The bound pair becomes a working unit that can change what the cell does.
S100 protein binding often produces a complex with new functional properties, such as altered enzymatic activity, changed localization or recruitment of additional factors [5,8]. Isolation and characterization of S100 protein-protein complexes has been formalized as an experimental workflow, reflecting the importance of the intact complex for downstream biology. In glioma, S100A16 binding to the CUL4A ligase machinery triggers LATS1 ubiquitin degradation and inhibits the Hippo pathway, illustrating how complex formation can directly reprogram signaling.
Downstream signaling and cellular outcomes
In simple terms: The complex then switches on or off specific cell behaviors.
Depending on the partner, S100 protein binding can drive proliferation, migration, implantation or inflammatory gene expression [1,2,3,7]. In embryo implantation, S100 protein family members participate in the molecular dialogue between embryo and endometrium. In breast tumor biology, S100 proteins are studied as markers and effectors of tumor progression. In rheumatoid arthritis, S100 protein family members contribute to synovial inflammation and joint damage.
Termination and reversibility of the interaction
In simple terms: When calcium levels drop, the complex can fall apart and the signal stops.
Because S100 protein binding is calcium-dependent, the interaction is reversible and can be terminated when local calcium concentrations decrease [1,6]. This reversibility allows the process to act as a dynamic switch rather than a permanent modification. Experimental isolation of S100 complexes therefore requires conditions that preserve calcium-dependent interactions, which is why specialized protocols have been developed.
Key Genes Involved in GO:0044548 S100 protein binding
The following genes and proteins are recurrently implicated in S100 protein binding and its downstream biology, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| S100A16 | Promotes proliferation via LATS1 degradation and Hippo pathway inhibition | Glioma development and proliferation models |
| S100 family members (generic) | Calcium-dependent binding to target proteins | Embryo implantation and reproductive biology |
| S100 proteins in breast tumor | Tumor progression and biomarker potential | Breast cancer research |
| pEL98 / S100-related protein | Binds nonmuscle tropomyosin | Cytoskeletal regulation and motility |
| Annexins | Form S100-annexin complexes | Structural and calcium-signaling studies |
| Transition metal-binding S100 proteins | Bind transition metals in addition to calcium | Metal-dependent regulation studies |
| S100 proteins in rheumatoid arthritis | Contribute to synovial inflammation | Inflammatory disease models |
| CUL4A | Ubiquitin ligase mediating LATS1 degradation upon S100A16 binding | Glioma signaling studies |
| LATS1 | Hippo pathway kinase degraded after S100A16-driven ubiquitination | Hippo pathway research |
| Nonmuscle tropomyosin | Cytoskeletal target of S100-related protein binding | Cytoskeleton and motility assays |
| Calcium-binding EF-hand proteins | Provide the calcium-sensing module of S100 proteins | Calcium signaling research [1,6] |
| S100-annexin complex components | Assemble calcium-dependent complexes | Structural biology and biochemistry |
| S100 protein-protein complex partners | General targets isolated by affinity methods | Interaction proteomics |
| Hippo pathway components | Downstream effectors of S100A16 binding | Cancer signaling |
| Implantation-related S100 targets | Mediate embryo-endometrium dialogue | Reproductive biology |
| Inflammation-associated S100 targets | Drive cytokine and immune responses | Rheumatoid arthritis research |
| Tumor-associated S100 targets | Support proliferation and survival | Breast cancer and glioma models [2,3] |
How Is S100 protein binding Regulated?
S100 protein binding is regulated primarily by intracellular calcium concentration, because calcium binding to the EF-hand motifs of S100 proteins controls exposure of the target-binding surface [1,6]. Transition metal binding can further modulate S100 protein behavior, adding a metal-dependent layer of regulation. The process is also regulated by the availability and post-translational state of the partner protein, as shown by the S100A16-CUL4A-LATS1 axis in glioma, where ubiquitin-ligase activity determines the fate of the bound target. In inflammatory settings, the local cytokine environment influences S100 protein family expression and therefore the probability of S100 protein binding events. Finally, experimental isolation of S100 complexes depends on preserving calcium-dependent interactions, which reflects the underlying regulatory logic of the process.
S100 protein binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| S100A16 | Glioma proliferation via Hippo pathway inhibition | Knockout and point-mutation glioma cell lines |
| S100 family members | Embryo implantation and reproductive disorders | Knockout and knock-in trophoblast models |
| S100 proteins in breast tumor | Breast cancer progression | Overexpression and knockout breast cancer cells |
| S100 proteins in rheumatoid arthritis | Synovial inflammation and joint damage | Knockout and overexpression immune cells |
| S100-annexin complex components | Calcium-dependent complex assembly | Tagged knock-in and structural models |
S100 protein binding in cancer
S100 protein binding is mechanistically linked to tumor progression. In glioma, S100A16 binding to the CUL4A ubiquitin ligase triggers LATS1 degradation and inhibits the Hippo pathway, thereby promoting cell proliferation. In breast tumor biology, S100 proteins are studied as markers and effectors of malignant progression. These findings position S100 protein binding as a candidate target for functional cancer genomics [2,3].
S100 protein binding in inflammatory and autoimmune disease
The S100 protein family plays a role in rheumatoid arthritis, where S100 proteins contribute to synovial inflammation and joint destruction. Because these effects depend on binding to partner proteins, GO:0044548 provides a framework for interpreting inflammatory signaling data. Targeting S100 protein binding interfaces is therefore of interest in autoimmune research.
S100 protein binding in reproduction and development
S100 protein family members participate in embryo implantation, a process that requires precise calcium-dependent interactions between embryonic and maternal cells. Disruption of S100 protein binding may therefore contribute to implantation failure, although the exact mechanisms remain an active area of research. This makes GO:0044548 relevant to reproductive biology and developmental studies.
From S100 protein binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an S100 protein abolish a specific binding event? | CRISPR knockout of the S100 gene |
| Does a point mutation in the EF-hand abolish calcium-dependent binding? | CRISPR point mutation of the S100 gene |
| Can a disease-associated S100 variant alter target binding? | Knock-in of the variant allele |
| Where does the S100-target complex localize in cells? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression of an S100 protein drive proliferation? | Overexpression cell model [2,3] |
| Which proteins bind a given S100 protein under calcium-rich conditions? | Affinity purification and interaction proteomics |
How to Study the S100 protein binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between S100 and target proteins | Validation of S100 protein binding |
| Crosslinking | Stabilization of transient S100-target complexes | Interaction detection in cell lysates |
| Affinity purification | Isolation of S100 protein-protein complexes | Interaction proteomics |
| Crystallography / NMR | Three-dimensional structure of S100-target interfaces | Mechanistic structural studies |
| Calcium and metal-binding assays | Metal occupancy of S100 EF-hand motifs | Biochemical regulation studies |
| Proliferation assays | Cell growth after S100 pathway perturbation | Cancer models such as glioma |
| Ubiquitination assays | Degradation of S100-bound targets | Hippo pathway studies |
| Implantation assays | Embryo-endometrium interaction | Reproductive biology |
Biochemical isolation of S100 protein complexes
Co-immunoprecipitation, crosslinking and affinity purification are standard methods for detecting S100 protein binding, and specialized protocols have been developed to isolate S100 protein-protein complexes while preserving calcium-dependent interactions. These approaches are often combined with mass spectrometry to identify partner proteins.
Structural analysis of S100-target interfaces
Structural methods such as crystallography and NMR have been used to define how S100 proteins engage annexins and other targets, revealing the molecular basis of calcium-dependent binding. Such studies provide the residue-level information needed to design point-mutation experiments.
Functional assays for S100-dependent phenotypes
Proliferation, migration and implantation assays are used to test the consequences of S100 protein binding in relevant cell types [1,2,3]. In glioma, proliferation assays combined with ubiquitination analysis have been used to dissect the S100A16-CUL4A-LATS1 axis.
Metal-binding and calcium-sensing assays
Because S100 proteins bind calcium and transition metals, metal-binding assays are used to determine how metal occupancy affects target recognition. These assays complement functional studies by defining the biochemical state of the S100 protein.
How CRISPR Can Be Used to Study GO:0044548 S100 protein binding
Knockout
CRISPR knockout of an S100 gene or its target is used to test whether the binding event is required for a phenotype, such as glioma proliferation driven by S100A16. Knockout models also help distinguish S100-dependent from S100-independent effects in implantation and inflammation research [1,7].
Point Mutation
Point mutations in EF-hand or interface residues can be introduced to dissect calcium dependence and binding specificity without removing the entire protein. Such models are valuable when the S100 protein has multiple functions and complete knockout would be confounding.
Knock-in
Knock-in of disease-associated variants or tagged alleles allows researchers to study S100 protein binding in a physiological context [3,8]. Tagged knock-in lines are particularly useful for isolating endogenous S100 complexes.
Overexpression
Overexpression of an S100 protein or its partner is used to test sufficiency, for example whether increased S100A16 drives proliferation through Hippo pathway inhibition. Overexpression models are also common in breast tumor and rheumatoid arthritis research [2,7].
How EDITGENE Supports S100 protein binding Research
Researchers studying S100 protein binding-related genes often need to determine whether a candidate gene is causally involved in a specific interaction or phenotype, rather than merely correlated with it. This requires precise genetic models that can remove, alter or tag the relevant proteins without confounding off-target effects. EDITGENE provides such models across the workflow, from initial knockout validation to sophisticated knock-in and library-based screening.
Contact EDITGENE today to design your custom CRISPR model for S100 protein binding research.
Frequently Asked Questions About S100 protein binding
What is GO:0044548 S100 protein binding?
GO:0044548 is a Gene Ontology biological_process term describing the binding of a protein to an S100-family calcium-binding protein, typically in a calcium-dependent manner [1,6].
What genes are involved in S100 protein binding?
Genes include S100A16 and other S100 family members, as well as partners such as annexins, nonmuscle tropomyosin, CUL4A and LATS1 [3,4,5].
Why is S100 protein binding important in cancer?
S100 protein binding can promote proliferation, as shown by S100A16-driven LATS1 degradation and Hippo pathway inhibition in glioma, and is linked to breast tumor progression [2,3].
How is S100 protein binding detected experimentally?
Common methods include co-immunoprecipitation, crosslinking, affinity purification and structural approaches such as crystallography and NMR [5,8].
Is S100 protein binding calcium-dependent?
Yes, S100 proteins are EF-hand calcium sensors that expose their target-binding surfaces after calcium binding, making the interaction calcium-dependent [1,6].
What diseases are associated with S100 protein binding?
Associated conditions include glioma, breast cancer, rheumatoid arthritis and implantation-related reproductive disorders [1,2,3,7].
Can CRISPR be used to study S100 protein binding?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are used to test the causal role of S100 proteins and their binding interfaces [3,8].
What is the role of S100A16 in glioma?
S100A16 promotes cell proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase, thereby inhibiting the Hippo pathway.
Do S100 proteins bind metals other than calcium?
Yes, transition metals can bind S100 proteins and modulate their behavior, adding another layer of regulation to S100 protein binding.
How are S100 protein complexes isolated?
Specialized protocols using co-immunoprecipitation, crosslinking and affinity purification have been developed to isolate S100 protein-protein complexes.
Conclusion
GO:0044548 S100 protein binding is a biologically_process term that captures a central mechanism by which calcium signals are converted into specific protein-protein interactions. The process depends on calcium-dependent activation of S100 proteins and their subsequent binding to partners such as annexins, tropomyosin and ubiquitin-ligase components [4,5,6]. Dysregulation of these interactions is implicated in cancer, inflammatory disease and reproductive disorders, making the term a useful framework for functional genomics [1,2,3,7]. With CRISPR-based knockout, point-mutation, knock-in and overexpression models, researchers can now test the causal contribution of S100 protein binding to disease phenotypes with high precision [3,8].
References
- 1. Sadigh AR et al.. 2019. S100 protein family and embryo implantation.. J Cell Biochem 120(12):19229-19244 PMID: 31270848
- 2. Li F et al.. 2014. S100 protein in breast tumor.. Indian J Cancer 51 Suppl 3:e67-71 PMID: 25818737
- 3. Hu Y et al.. 2023. S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development.. Int J Biol Sci 19(7):2034-2052 PMID: 37151881
- 4. Takenaga K et al.. 1994. Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin.. J Cell Biol 124(5):757-68 PMID: 8120097
- 5. Rintala-Dempsey AC et al.. 2008. S100-annexin complexes--structural insights.. FEBS J 275(20):4956-66 PMID: 18795951
- 6. Gilston BA et al.. 2016. Binding of transition metals to S100 proteins.. Sci China Life Sci 59(8):792-801 PMID: 27430886
- 7. Wu YY et al.. 2022. Role of the S100 protein family in rheumatoid arthritis.. Arthritis Res Ther 24(1):35 PMID: 35101111
- 8. Kiss B et al.. 2019. Isolation and Characterization of S100 Protein-Protein Complexes.. Methods Mol Biol 1929:325-338 PMID: 30710283
